A study to evaluate the clinical validity of a ctDNA-based MRD test designed to detect breast cancer progression or recurrence following surgery

Status: Ongoing

About

A study to evaluate the clinical validity of a ctDNA-based MRD test designed to detect breast cancer progression or recurrence following surgery


Details

MONITOR-Breast: Monitoring cell-free tumor DNA as a marker of recurrence in Breast Cancer

 

Sponsor: Myriad Genetics

Sponsors

HOPE Cancer Center

Hope Cancer Center

Contact

Contact UT Clinical
Scroll to Top